Purpose: To compare the efficacy and safety profile of oral azithromycin
Purpose: Meibomian gland dysfunction (MGD) is a common clinical problem that is
The disease is a chronic and diffuse abnormality of the meibomian gland that is always accompanied by subsequent
Meibomian gland dysfunction (MGD) is a common disease that is often overlooked in clinic; the disease may involve inflammation, hypersecretion, and abnormal excreta of the meibomian glands
1097/ICO
Objective: To determine if the AEs of a 3-week course of oral azithromycin were equivalent to the
19 Azasite (azithromycin ophthalmic solution 1%, Akorn) was FDA approved for bacterial conjunctivitis, but has been well-tolerated for off-label
This prospective, observational, open-label clinical trial documents the improvement in both clinical signs and symptoms
If you catch the problem in time and treat the patient intensively, however, you can achieve good outcomes
5% eyedrops compared with oral doxycycline in patients with moderate to severe meibomian gland dysfunction (MGD)
Oral azithromycin versus doxycycline in meibomian gland dysfunction: a randomised double-masked open-label clinical trial
Meibomian gland dysfunction (MGD) is a common clinical problem responsible for symptoms and signs of eyelid irritation and is frequently a cause of evaporative dry eye
The search terms were: (antibiotics OR azithromycin OR doxycycline OR minocycline) AND (dry eye disease OR meibomian gland OR blepharitis anterior OR blepharitis posterior OR chronic
We performed a systematic search of electronic databases for all peer-reviewed published studies which included clinical outcomes of oral antibiotic MGD 5-day oral azithromycin is recommended for its better effect on improving the signs, better overall clinical response and shorter duration of treatment
s
9%